Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (291-300 of 457) with videos related to

Pageof 46
Sort By:
American Journal of Clinical Pathology|May 12, 2021
Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 MutationsElise R Venable, Dong Chen, Constance P Chen, et al.
British Journal of Haematology|February 21, 2006
Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant ResearchHillard M Lazarus, Waleska S Pérez, John P Klein, et al.
Blood|October 16, 2009
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)David I Marks, Elisabeth M Paietta, Anthony V Moorman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2020
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe StudyGalen E Switzer, Jessica G Bruce, Deidre M Kiefer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2024
Palliative Care for Patients With Cancer: ASCO Guideline UpdateJustin J Sanders, Sarah Temin, Arun Ghoshal, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Haematologica|May 30, 2015
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemiaJoshua F Zeidner, Matthew C Foster, Amanda L Blackford, et al.
Transfusion|July 13, 2020
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902Francine M Foss, Xin Victoria Wang, Selina M Luger, et al.
Blood Cancer Journal|September 6, 2023
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemiaBeth A Pitel, Cinthya Zepeda-Mendoza, Zohar Sachs, et al.
Pageof 46

Showing results (291-300 of 457) with videos related to

Sort By:
Pageof 46
American Journal of Clinical Pathology|May 12, 2021
Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 MutationsElise R Venable, Dong Chen, Constance P Chen, et al.
British Journal of Haematology|February 21, 2006
Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant ResearchHillard M Lazarus, Waleska S Pérez, John P Klein, et al.
Blood|October 16, 2009
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)David I Marks, Elisabeth M Paietta, Anthony V Moorman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2020
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe StudyGalen E Switzer, Jessica G Bruce, Deidre M Kiefer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2024
Palliative Care for Patients With Cancer: ASCO Guideline UpdateJustin J Sanders, Sarah Temin, Arun Ghoshal, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Haematologica|May 30, 2015
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemiaJoshua F Zeidner, Matthew C Foster, Amanda L Blackford, et al.
Transfusion|July 13, 2020
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902Francine M Foss, Xin Victoria Wang, Selina M Luger, et al.
Blood Cancer Journal|September 6, 2023
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemiaBeth A Pitel, Cinthya Zepeda-Mendoza, Zohar Sachs, et al.
Pageof 46